Briefcases -- Medical Devices -- SGLT2 INHIBITORS

SGLT2 INHIBITORS

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

SGLT2 Inhibitors FDA and Other Evidence
Added: December 7, 2015
0 folders
6 docs
Canadian Invonaka Lawsuit
Added: December 7, 2015
0 folders
1 docs
SGLT2 FDA Caution May 2015
Added: February 3, 2016
0 folders
0 docs
SGLT2 Inhibitors Evidence
Added: February 3, 2016
0 folders
2 docs
About DKA Science and Evidence
Added: February 20, 2016
0 folders
3 docs
Johnson and Johnson Stockholder Lawsuit Re: Levaguin
Added: February 12, 2016
0 folders
1 docs
SGLT2 Inhibitors Dec 2015 New Black Box Warning
Added: February 3, 2016
0 folders
1 docs
Jaridance FDA (Intital Approval 2014)
Added: February 15, 2016
0 folders
0 docs
Glucotoxicity, Insulin Resistance and DKA
Added: February 20, 2016
0 folders
2 docs
Stroke and Heart Attack, PE and DVT in DKA
Added: February 20, 2016
0 folders
8 docs
How SGLT2s Work and Why they Cause DKA (Theory)
Added: February 20, 2016
0 folders
14 docs

Quick Access

File Name Posted
SGLT2 Inhibitors Dec 2015 Warning.pdf December 7, 2015
Dapagliflozin improves muscle insulin but inheances endrogenous gluscose production.pdf February 20, 2016
J & J Stock Holders RICO Re: Levaquin Complaints February 12, 2016
Stroke and Heart Attack in DKA.pdf February 20, 2016
Invonaka Lawsuit Filed in Canada.pdf December 7, 2015
SGLT2 Inhibitors Dec 2015 Warning.pdf February 3, 2016
DKA and Thrombotic Complications.pdf February 20, 2016
Glucotoxicity.pdf February 20, 2016